HungaroTrial, a privately held Contract Research Organization is delighted to announce the opening of its new wholly-owned subsidiary office in Prague, Czech Republic.
The new office strengthens the company’s existing presence in the CEE region and further boosts its growth and expansion, providing full operational coverage in this key emerging region.
HungaroTrial has been operating for eighteen years in the drug development industry and are proud to add to their five offices in the Central and Eastern European region. This success is the result of our unique commitment to deliver our clients’ needs with high quality services, on time and on budget.
Share this
